SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
NXTC

NextCure, Inc. (NASDAQ:NXTC)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$6.45-$0.33 (-4.87%)
 
Market cap
$29.5M
Insider Score
Health Score
Analyst consensus
Listed since
May 9, 2019
Market Cap$29.53M-38.6%
Revenue (ttm)$0
Net Income-$40.97M+29.4%
EPS-$8.65+64.2%
Shares Out4.58M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume30,624
Open$6.76
Previous Close$6.78
Day's Range$6.29 - $6.93
52-Week Range$1.55 - $15.74
Beta1.20
AnalystsBuy
Price Target$20.00(+210.08%)
Earnings DateMar 4, 2027
-3.24% (1D)
No price history available.

About NXTC

NextCure, Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative immunotherapies. Its core mission is to combat cancer and various other immune-related conditions by reactivating normal immune system function. The company's leading investigational compound, NC318, is currently in Phase II clinical trials, focusing on the treatment of advanced or metastatic solid tumors. Additionally, NextCure is progressing NC410 through Phase I studies; this novel immunomedicine is engineered to counteract immune suppression mediated by Leukocyte-Associated Immunoglobulin-like Receptor 1 (LAIR-1). Another asset, NC762, is an immunotherapeutic designed to target the human B7 homolog 4 protein (B7-H4). Furthermore, NC525, a distinct LAIR-1 antibody, is undergoing preclinical assessment for its potential efficacy against acute myeloid leukemia, specifically targeting blast cells and leukemic stem cells. Beyond these specific pipeline candidates, NextCure's broader research and development efforts encompass the preclinical evaluation of other promising immunomodulatory antibodies and molecules. The company operates under a licensing agreement with Yale University. NextCure, Inc. was established in 2015 and maintains its corporate headquarters in Beltsville, Maryland.

Address
2850 Quarry Lake Drive, Beltsville, MD, 21209, US
Market Cap
30 million
Employees
40
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$184.80K
Bought
$1.85M

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Fair
From NXTC’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-4.87%
5 Days
+2.22%
1 Month
+19.00%
6 Months
-36.76%
1 Year
-38.63%

$NXTC stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in NXTC holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by NXTC's directors and management

Net Shares Purchased by Insiders−400k−200k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

NXTC Estimated quarterly lobbying spending

Source: U.S. Senate LDA

NXTC Revenue by Segment

$19.93MTotal
Upfront cash payment$12.00M60.22%
Professional services$2.82M14.14%
Clinical product candidates$2.50M12.57%
Employee costs$785.00K3.94%
Other R&D$629.00K3.16%
Nonclincal product candidates$617.00K3.10%
Other G&A$382.00K1.92%
Insurance$192.00K0.96%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New NXTC patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to NXTC from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in NXTC

VTIVanguard Morningstar Total Stock Market ETF$578.28K
VXFVanguard Extended Market ETF$211.80K
IWCiShares Micro-Cap ETF$73.66K
PQSGPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF$20.66K
DFMCU.S. Micro Cap Portfolio ETF$18.37K
DFACDimensional - US Core Equity 2 ETF$400.02

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from NXTC’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
0
Analyst Ratings
40% of score
99
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
19
Sells
1
Buy Value
$1.85M
Distinct Buyers
1

Insider Score Trend Over Time

-38.0 since Aug 21
0255075100Aug 21 — Insider Score 38.0Aug 22 — Insider Score 38.0Aug 23 — Insider Score 38.0Aug 24 — Insider Score 38.0Aug 25 — Insider Score 38.0Aug 26 — Insider Score 38.0Aug 27 — Insider Score 38.0Aug 28 — Insider Score 38.0Aug 29 — Insider Score 38.0Aug 30 — Insider Score 38.0Aug 31 — Insider Score 38.0Sep 1 — Insider Score 0.0Sep 2 — Insider Score 0.0Sep 3 — Insider Score 0.0Sep 4 — Insider Score 0.0Sep 5 — Insider Score 0.0Sep 6 — Insider Score 0.0Sep 7 — Insider Score 0.0Sep 8 — Insider Score 0.0Sep 9 — Insider Score 0.0Sep 10 — Insider Score 0.0Sep 11 — Insider Score 0.0Sep 12 — Insider Score 0.0Sep 13 — Insider Score 0.0Sep 14 — Insider Score 0.0Sep 15 — Insider Score 0.0Sep 16 — Insider Score 0.0Sep 17 — Insider Score 0.0Sep 18 — Insider Score 0.0Sep 19 — Insider Score 0.0Sep 20 — Insider Score 0.0Sep 21 — Insider Score 0.0Sep 22 — Insider Score 0.0Sep 23 — Insider Score 0.0Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 38.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Aug 21Sep 12Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

PQSGPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF0.16%

Weight is the stock’s share of each fund’s holdings.